Innovation Pharmaceuticals Inc (IPIX)

[thefamilyman]

Our previous Covid study administered Brilacidin too late in the progression of the disease. The damage caused by the virus had already been done. I’ve got to believe that if they administered an IV of Brilacidin when the patient first presented at the hospital or doctor’s office, the results would have been much more positive. And now we have evidence that it might not even matter what disease the sick person presents with. Brilacidin may well cure (or at least slow the progression or reduce the damage) of a wide variety (most?) viruses AND bacteria. It could (potentially) be the first and best line of defense if given early enough in the process.